Jon M. Foster, Executive Vice President and Chief Operating Officer of HCA Healthcare, Inc. (NYSE:HCA), filed a Form 4 on November 6, 2026, disclosing a series of common stock transactions dated November 4 and November 6, 2026.

Key Highlights

  • Stock appreciation rights exercised: Foster exercised 35,880 stock appreciation rights on November 4, 2026, at an exercise price of $145.24, acquiring 35,880 shares of common stock.
  • Tax withholding disposition: 20,309 shares were disposed of on November 4, 2026, at $510.70 per share under transaction code F (tax withholding).
  • Open-market sales on November 4: 10,000 shares were sold at a weighted average price of $514.0698, with individual transaction prices ranging from $513.87 to $514.24.
  • Open-market sales on November 6: Multiple sale transactions totaling 21,713 shares were executed at weighted average prices ranging from approximately $491.9817 to $498.971 per share.
  • Ownership transfer: On November 4, 2026, Foster transferred 16,142 shares from a trust to direct ownership at $503.525 per share, described in the filing as a change in form of beneficial ownership under Rule 16a-13.
  • Remaining direct holdings: Following all reported transactions, Foster directly owned 10,000 shares of common stock as of November 6, 2026.
  • Indirect holdings: Foster also holds shares indirectly through multiple trusts, including 72,308 shares via LCF Trust, 51,453 shares via JMF Trust, 19,985 shares via JMF Family Trust, 11,566 shares via 2025 GRAT, and 13,062 shares via 2026 GRAT.

Foster's Multi-Day Share Transactions at HCA Healthcare

According to the filing, Foster's activity on November 4, 2026 began with the exercise of 35,880 stock appreciation rights at a conversion price of $145.24 per share. The filing notes these rights "vested in four equal annual installments beginning on January 29, 2021." Following the exercise, 20,309 shares were withheld for taxes at $510.70 per share, and 10,000 shares were sold at a weighted average price of $514.0698. Also on November 4, the filing discloses that Foster transferred 16,142 shares from a trust to direct ownership, a transaction the filing states "did not change the total number of shares of common stock of the Issuer of which the reporting person may be deemed to have beneficial ownership."

On November 6, 2026, the filing reports seven separate open-market sale transactions totaling 21,713 shares, executed at weighted average prices between $491.9817 and $498.971. Each sale was conducted across multiple price sub-ranges, with the filing specifying that full price detail for each transaction is available upon request to HCA Healthcare, the SEC staff, or any security holder.

After all reported transactions, the filing states Foster directly held 10,000 shares. Indirect beneficial ownership is reported across four trusts and two grantor retained annuity trusts (GRATs), with the largest indirect position being 72,308 shares held through the LCF Trust, for which Foster serves as trustee. The filing was signed by Kevin A. Ball as Attorney-in-Fact on November 6, 2026.

What Was Disclosed

The Form 4 discloses stock appreciation right exercises, tax-related share dispositions, open-market sales, and an intra-trust ownership transfer by HCA Healthcare's EVP and COO, Jon M. Foster, occurring on November 4 and November 6, 2026.